InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Johnson Marvin. Director active across 1 company, notably Marinus Pharmaceuticals, INC.. Aggregated, 5 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €834. Activity tracked since 17 April 2023. The latest transaction was disclosed on 7 February 2025 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Johnson Marvin is a declarant linked to Marinus Pharmaceuticals, INC., where he is a Director. He has 5 filings in total, and among the recent filings available, the transactions run from 2023-04-19 to 2025-02-11, with EUR 0 of buys and EUR 3688 of sells, and the listed transaction nature is Attribution.